Nicholas J. Diamond, JD, LLM, MBe is an advisor and legal academic. He is an expert in the intersection of economic issues (especially foreign investment), human rights (especially health), and the law. His interests span the fields of public health law, public international law, international arbitration, business and human rights, and ethics.
Since 2017, Nick has worked at Avalere, a leading advisory firm in the US, where he counsels multinational biopharmaceutical companies and other entities on US and international health policy and regulatory matters.
Since 2017, Nick has served as an Adjunct Professor of Law at the Georgetown University Law Center, where he teaches several courses on legal issues in public health and bioethics. He is also an Associate Scholar in the Center for Global Health at the University of Pennsylvania. He holds related affiliations as a member of the Executive Committee of the Framework Convention on Global Health Alliance (a Geneva-based NGO) and a Contributor to Harvard Law’s Bill of Health Blog.
Since 2018, Nick has been a PhD candidate in public international law at Leiden Law School, focusing on investment treaty arbitration, treaty interpretation, and human rights. His dissertation argues for a novel approach to addressing the tensions between investment treaty arbitration and human rights, based on both practical considerations imbedded in the case law and the limitations of traditional methods of treaty interpretation. He holds related affiliations as an Assistant Editor of Wolters Kluwer’s Kluwer Arbitration Blog, a Contributor to Oxford University Press’ Investment Claims, and a member of the Peer Review Board of the ICSID Review – Foreign Investment Law Journal.
Nick’s writing has been published in law reviews, peer-reviewed journals, and major media outlets. His writing has also been discussed or featured in major media outlets (e.g., The Washington Post, Slate, Forbes). He has given invited talks in various academic and industry fora, as well as frequently appeared on US news programs (e.g., Bloomberg, MSNBC) as an expert commentator.
Earlier in his career, Nick led global market strategy for the health sector at MarkLogic, one of the few privately owned Silicon Valley technology companies valued at over $1B, as well as served in advisory roles to the US government during implementation of landmark healthcare reform legislation. He has previously taught at The George Washington University (2016-19) and Drexel University (2013-14), as well as served as an Adjunct Fellow in the University of Pennsylvania’s Center for Public Health Initiatives (2016-19).
Nick trained and qualified as a lawyer in the US, and holds graduate degrees in global health law and bioethics. He is based in Washington, DC.
Since 2017, Nick has worked at Avalere, a leading advisory firm in the US, where he counsels multinational biopharmaceutical companies and other entities on US and international health policy and regulatory matters.
Since 2017, Nick has served as an Adjunct Professor of Law at the Georgetown University Law Center, where he teaches several courses on legal issues in public health and bioethics. He is also an Associate Scholar in the Center for Global Health at the University of Pennsylvania. He holds related affiliations as a member of the Executive Committee of the Framework Convention on Global Health Alliance (a Geneva-based NGO) and a Contributor to Harvard Law’s Bill of Health Blog.
Since 2018, Nick has been a PhD candidate in public international law at Leiden Law School, focusing on investment treaty arbitration, treaty interpretation, and human rights. His dissertation argues for a novel approach to addressing the tensions between investment treaty arbitration and human rights, based on both practical considerations imbedded in the case law and the limitations of traditional methods of treaty interpretation. He holds related affiliations as an Assistant Editor of Wolters Kluwer’s Kluwer Arbitration Blog, a Contributor to Oxford University Press’ Investment Claims, and a member of the Peer Review Board of the ICSID Review – Foreign Investment Law Journal.
Nick’s writing has been published in law reviews, peer-reviewed journals, and major media outlets. His writing has also been discussed or featured in major media outlets (e.g., The Washington Post, Slate, Forbes). He has given invited talks in various academic and industry fora, as well as frequently appeared on US news programs (e.g., Bloomberg, MSNBC) as an expert commentator.
Earlier in his career, Nick led global market strategy for the health sector at MarkLogic, one of the few privately owned Silicon Valley technology companies valued at over $1B, as well as served in advisory roles to the US government during implementation of landmark healthcare reform legislation. He has previously taught at The George Washington University (2016-19) and Drexel University (2013-14), as well as served as an Adjunct Fellow in the University of Pennsylvania’s Center for Public Health Initiatives (2016-19).
Nick trained and qualified as a lawyer in the US, and holds graduate degrees in global health law and bioethics. He is based in Washington, DC.